Cite
HARVARD Citation
Gupte, A. et al. (2022). Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study. European respiratory journal. 59 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gupte, A. et al. (2022). Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study. European respiratory journal. 59 (4), p. . [Online].